Breaking News Instant updates and real-time market news.

VBLT

VBL Therapeutics

07:02
11/29/16
11/29
07:02
11/29/16
07:02

VBL Therapeutics announces OS data for VB-111 Phase 2 study

VBL Therapeutics announced top-line results from its exploratory Phase 2 study of VB-111 in patients with advanced, differentiated thyroid cancer. As previously announced, this trial met its primary endpoint, which was defined as 25% progression-free survival at 6 months, in heavily-pretreated patients with late-stage disease. A dose-dependent response was seen, with 35% of patients reaching PFS-6 in the therapeutic dose cohort, versus 25% in a low-dose cohort. Given this positive clinical response, the Company continued to follow patients for overall survival, or OS, data, which was not a primary endpoint. Although the trial included a small number of patients and was not powered to show OS differences, the new data show a dose-response and evidence of an overall survival benefit in the cohort of patients treated with multiple therapeutic doses of VB-111, compared to patients who received a single low dose of VB-111. Only one patient remained alive in the low-dose cohort, compared to a tail of about 50% in the high dose group.

  • 29

    Nov

VBLT VBL Therapeutics

06/06/16
CHDN
06/06/16
NO CHANGE
CHDN
VBL Therapeutics data provides enhanced visibility, says Chardan
Chardan noted that VBL announced that in a Phase II trial involving glioblastoma multiforme patients, VBL's VB-111 drug followed by VB-111 with Avastin led to a statistically significant increase in median overall survival, or OS, of 59 weeks compared to 32 weeks of OS in patients who received VB-111 followed by Avastin only. The firm says that the data reduces the uncertainty of the Phase III trial of VB-111 and "further reinforces the unprecedented nature" of VB-111's Phase II data. The firm keeps a $20 price target and Buy rating on the shares.
06/06/16
ROTH
06/06/16
NO CHANGE
Target $22
ROTH
Buy
VBL Therapeutics' ASCO presentations underscore potential, says Roth Capital
Roth Capital analyst Joseph Pantginis said VBL Therapeutics' two poster presentations on VB-111 at ASCO underscore the platform's potential in various cancers. Most notably, maturing data from an ongoing trial in ovarian cancer showed an "impressive" dose-response relationship, said Pantginis, who keeps a Buy rating and $22 price target on VBL shares.
06/07/16
CHDN
06/07/16
NO CHANGE
Target $20
CHDN
Buy
Chardan continues to see significant upside for VBL Therapeutics
Chardan continues to see significant upside for VBL Therapeutics shares given VB-111 has convincing efficacy signals for rGBM, ovarian, and thyroid cancer types, an immune-therapeutic effect for VB-111 has been supported in the rGBM and ovarian trials, and the product has orphan drug designations in the US and Euripe for rGBM, Fast Track designation by the FDA for rGBM, and a special protocol assessment by the FDA for the Phase III program in rGBM. Chardan rates VBL Therapeutics a Buy with a $20 price target on shares.
06/28/16
HCWC
06/28/16
INITIATION
Target $11
HCWC
Buy
VBL Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started VBL Therapeutics with a Buy rating and $11 price target.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$81.29

6.92 (9.30%)

, BBY

Best Buy

$42.01

-2.12 (-4.80%)

13:05
03/01/17
03/01
13:05
03/01/17
13:05
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

LOW

Lowe's

$81.29

6.92 (9.30%)

BBY

Best Buy

$42.01

-2.12 (-4.80%)

KMX

CarMax

$65.22

0.68 (1.05%)

MCD

McDonald's

$129.21

1.5608 (1.22%)

GOOG

Alphabet

$823.21

-6.07 (-0.73%)

GOOGL

Alphabet Class A

$844.93

-4.74 (-0.56%)

CMCSA

Comcast

$37.42

-0.11 (-0.29%)

CMCSK

Comcast

FOX

21st Century Fox

$29.35

-0.66 (-2.20%)

CBS

CBS

$67.48

1.56 (2.37%)

DIS

Disney

$111.73

1.635 (1.49%)

LOGM

LogMeln

$91.75

-2 (-2.13%)

FOLD

Amicus

$6.49

0.06 (0.93%)

WTW

Weight Watchers

$18.74

4.35 (30.23%)

PANW

Palo Alto Networks

$118.06

-33.84 (-22.28%)

AMBA

Ambarella

$58.95

-0.83 (-1.39%)

ETSY

Etsy

$12.12

-0.67 (-5.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 05

    Apr

TGT

Target

$57.94

-0.8346 (-1.42%)

, AAPL

Apple

$136.99

0.06 (0.04%)

13:02
03/01/17
03/01
13:02
03/01/17
13:02
Periodicals
Target returns some iPhone SE stock ahead of Apple press event, MacRumors says »

Target (TGT) told its…

TGT

Target

$57.94

-0.8346 (-1.42%)

AAPL

Apple

$136.99

0.06 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 19

    Mar

CMTL

Comtech

$11.41

-0.37 (-3.14%)

13:02
03/01/17
03/01
13:02
03/01/17
13:02
Hot Stocks
Comtech in $4.5M pact for navigation, telematics services »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRA

Vera Bradley

$10.46

-0.36 (-3.33%)

13:01
03/01/17
03/01
13:01
03/01/17
13:01
Options
Earnings hedge in Vera Bradley »

Earnings hedge in Vera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SKLN

Skyline Medical

$1.92

0.07 (3.78%)

12:57
03/01/17
03/01
12:57
03/01/17
12:57
Technical Analysis
Skyline Medical spikes higher on extremely heavy volume, retraces some gains »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

$1.92

0.07 (3.78%)

12:52
03/01/17
03/01
12:52
03/01/17
12:52
Hot Stocks
Skyline Medical soars after receiving contract from Vizient »

Skyline Medical has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$16.20

-0.55 (-3.28%)

12:50
03/01/17
03/01
12:50
03/01/17
12:50
Conference/Events
Kornit Digital management to meet with Canaccord »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

TWTR

Twitter

$15.69

-0.085 (-0.54%)

12:49
03/01/17
03/01
12:49
03/01/17
12:49
Hot Stocks
Twitter says launching algorithm-based safety tools »

Twitter announced in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 19

    Mar

WLL

Whiting Petroleum

$11.32

0.47 (4.33%)

12:47
03/01/17
03/01
12:47
03/01/17
12:47
Conference/Events
Whiting Petroleum management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

12:45
03/01/17
03/01
12:45
03/01/17
12:45
General news
Atlanta Fed's Q1 GDPNow estimate was slashed to 1.8% »

Atlanta Fed's Q1…

PNW

Pinnacle West

$82.08

-0.11 (-0.13%)

12:44
03/01/17
03/01
12:44
03/01/17
12:44
Hot Stocks
APS, group reach consensus rate review agreement »

Arizona Public Service, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCC

Ares Capital

$17.75

-0.04 (-0.22%)

12:41
03/01/17
03/01
12:41
03/01/17
12:41
Options
Ares Capital attracts a large spread trade »

Ares Capital attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$30.80

-0.05 (-0.16%)

12:37
03/01/17
03/01
12:37
03/01/17
12:37
Conference/Events
Merit Medical management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

  • 14

    Mar

MSG

Madison Square Garden

$185.32

5.96 (3.32%)

12:36
03/01/17
03/01
12:36
03/01/17
12:36
Hot Stocks
Madison Square Garden in 'active' talks to bring Grammys back to MSG »

The Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$118.56

-33.34 (-21.95%)

12:33
03/01/17
03/01
12:33
03/01/17
12:33
Downgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

IBKR

Interactive Brokers

$36.71

-0.98 (-2.60%)

12:32
03/01/17
03/01
12:32
03/01/17
12:32
Hot Stocks
Interactive Brokers reports February DARTS down 12% y/y »

Interactive Brokers Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$17.38

0.06 (0.35%)

12:32
03/01/17
03/01
12:32
03/01/17
12:32
Hot Stocks
Square acquires OrderAhead pickup business »

Square announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWFT

Swift Transportation

$22.13

0.41 (1.89%)

12:31
03/01/17
03/01
12:31
03/01/17
12:31
Options
Second day of bullish flow in Swift Transportation »

Second day of bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$398.84

11.38 (2.94%)

, WETF

WisdomTree

$9.11

-0.21 (-2.25%)

12:31
03/01/17
03/01
12:31
03/01/17
12:31
Hot Stocks
Labor Department proposes extension of fiduciary rule applicability dates »

The U.S. Department of…

BLK

BlackRock

$398.84

11.38 (2.94%)

WETF

WisdomTree

$9.11

-0.21 (-2.25%)

LM

Legg Mason

$37.70

-0.02 (-0.05%)

IVZ

Invesco

$32.64

0.45 (1.40%)

WDR

Waddell & Reed

$19.66

0.415 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

  • 12

    Apr

  • 11

    May

MCD

McDonald's

$128.07

0.42 (0.33%)

12:26
03/01/17
03/01
12:26
03/01/17
12:26
Technical Analysis
McDonald's trades higher following lift of halt »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

MCD

McDonald's

$128.07

0.42 (0.33%)

12:25
03/01/17
03/01
12:25
03/01/17
12:25
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's up 1.4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

MSFT

Microsoft

$63.98

-0.25 (-0.39%)

, FCN

FTI Consulting

$41.21

0.97 (2.41%)

12:25
03/01/17
03/01
12:25
03/01/17
12:25
Conference/Events
FTI Consulting co-hosts a webinar with Microsoft »

Webinar entitled,…

MSFT

Microsoft

$63.98

-0.25 (-0.39%)

FCN

FTI Consulting

$41.21

0.97 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 14

    Mar

  • 09

    May

MYL

Mylan

$41.85

-0.59 (-1.39%)

12:25
03/01/17
03/01
12:25
03/01/17
12:25
Conference/Events
Mylan to host investor day with a conference call hook-up »

CEO Bresch holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

  • 28

    Mar

  • 03

    Sep

  • 09

    Oct

MCD

McDonald's

$128.07

0.42 (0.33%)

12:23
03/01/17
03/01
12:23
03/01/17
12:23
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ANF

Abercrombie & Fitch

$11.20

-0.565 (-4.80%)

12:21
03/01/17
03/01
12:21
03/01/17
12:21
Options
Abercrombie puts outpace calls 3:1 as shares fall before earnings »

Abercrombie puts outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.